By Lilit February 1, 2026 - 3:24pm

Raising funding for digital health startups is becoming increasingly challenging. According to a CB Insights report, the second quarter of 2025 marked a five-year low in deal volume across all verticals. Digital therapeutics startups are no exception: regulatory and approval barriers, high clinical validation costs, and lengthy https://www.darly.solutions/blog/7-key-success-factors-for-digital-therapeutics-startups sales cycles make commercialization more challenging than for digital health applications unrelated to digital therapeutics. The Darly.Solutions company fully supports the development and creation of a user-friendly user experience across all business sectors.